Peter Gottlieb
Overview
Explore the profile of Peter Gottlieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tibrewal C, Modi N, Bajoria P, Dave P, Rohit R, Patel P, et al.
Cureus
. 2023 Aug;
15(7):e41956.
PMID: 37588324
Asthma, a prevalent chronic respiratory illness, affects a substantial number of individuals worldwide, with an estimated occurrence of 358 million cases. Evidence for the benefits of vitamin D in treating...
2.
Sharma S, Tan X, Boyer J, Clarke D, Costanzo A, Abe B, et al.
Sci Transl Med
. 2023 Jul;
15(703):eade3614.
PMID: 37406136
The endocrine pancreas is one of the most inaccessible organs of the human body. Its autoimmune attack leads to type 1 diabetes (T1D) in a genetically susceptible population and a...
3.
Shin D, Kim J, Gottlieb P, Vaisbuch Y, Puria S, Cho J, et al.
Sci Rep
. 2021 Aug;
11(1):16775.
PMID: 34408166
Acoustic hearing aids generate amplified sound in the ear canal, and they are the standard of care for patients with mild to moderate sensorineural hearing loss. However, because of their...
4.
Triolo T, Pyle L, Seligova S, Yu L, Simmons K, Gottlieb P, et al.
J Transl Autoimmun
. 2021 Mar;
4:100089.
PMID: 33748733
Objective: Biomarkers are needed to characterize heterogeneity within populations at risk for type 1 diabetes. The ratio of proinsulin to C-peptide (PI:C ratio), has been proposed as a biomarker of...
5.
Sharma S, Pettus J, Gottschalk M, Abe B, Gottlieb P, Teyton L
Diabetes
. 2019 Sep;
68(10):1886-1891.
PMID: 31540941
Type 1 diabetes is the prototypical CD4 T cell-mediated autoimmune disease. Its genetic linkage to a single polymorphism at position 57 of the HLA class II DQβ chain makes it...
6.
Simmons K, Fouts A, Pyle L, Clark P, Dong F, Yu L, et al.
Int J Mol Sci
. 2019 Aug;
20(16).
PMID: 31398795
Islet autoantibody (iAb)-positive individuals have a high risk of progression to type 1 diabetes (T1D), although the rate of progression is highly variable and factors involved in the rate of...
7.
Harms R, Lorenzo-Arteaga K, Ostlund K, Smith V, Smith L, Gottlieb P, et al.
Front Immunol
. 2018 Nov;
9:2332.
PMID: 30405601
We analyzed T cell subsets from cryopreserved PBMC obtained from the TrialNet Pathway to Prevention archives. We compared subjects who had previously seroconverted for one or more autoantibodies with non-seroconverted,...
8.
James E, Abreu J, McGinty J, Odegard J, Fillie Y, Hocter C, et al.
Diabetologia
. 2017 Dec;
61(3):658-670.
PMID: 29196783
Aims/hypothesis: Validated biomarkers are needed to monitor the effects of immune intervention in individuals with type 1 diabetes. Despite their importance, few options exist for monitoring antigen-specific T cells. Previous...
9.
Santa Maria P, Gottlieb P, Maria C, Kim S, Puria S, Yang Y
Tissue Eng Part A
. 2017 Feb;
23(9-10):436-444.
PMID: 28142401
We aim to demonstrate that regeneration of chronic tympanic perforations with heparin-binding epidermal growth factor-like growth factor (HB-EGF) delivered by an injectable hydrogel restored hearing to levels similar to that...
10.
Fouts A, Pyle L, Yu L, Miao D, Michels A, Krischer J, et al.
Diabetes Care
. 2016 Jul;
39(10):1738-44.
PMID: 27456836
Objective: To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population. Research Design And Methods: TrialNet subjects who were...